ORVILLE G KOLTERMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORVILLE G KOLTERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORVILLE G KOLTERMAN. ORVILLE G KOLTERMAN is Senior Vice President in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Clinical Affairs in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Clinical and Regulatory in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Research & Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Medical Officer in AMYLIN PHARMACEUTICALS INC ($AMLN).
Latest Insider Trading Transactions of ORVILLE G KOLTERMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 0.00 | 35,000 | 0 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 41.34 | 52,582 | 2,173,740 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 36.90 | 67,289 | 2,482,964 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 24.87 | 60,980 | 1,516,573 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 22.60 | 60,576 | 1,369,018 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.85 | 57,243 | 1,079,031 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.01 | 53,356 | 960,942 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.54 | 58,838 | 973,181 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.02 | 42,099 | 674,426 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 15.03 | 19,781 | 297,308 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 9.02 | 42,186 | 380,518 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 41.34 | 2,418 | 99,960 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 22.60 | 4,424 | 99,982 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.85 | 7,757 | 146,219 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 18.01 | 6,644 | 119,658 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.54 | 6,162 | 101,919 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 16.02 | 7,901 | 126,574 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | J | 15.03 | 5,219 | 78,442 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 2,990 | 92,690 | 0 | 3 K to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 4,984 | 154,504 | 2,990 | 8 K to 3 K (-62.50 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 12,767 | 395,777 | 0 | 12.8 K to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 415 | 12,865 | 0 | 415 to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | U | 31.00 | 192,146 | 5,956,526 | 415 | 192.6 K to 415 (-99.78 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | J | 31.00 | 71,349 | 2,211,819 | 192,561 | 263.9 K to 192.6 K (-27.04 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | J | 31.00 | 71,349 | 2,211,819 | 263,910 | 192.6 K to 263.9 K (+37.05 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.95 | 13,091 | 156,437 | 0 | |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.95 | 7,209 | 86,148 | 0 | |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 30.80 | 1,777 | 54,723 | 192,561 | 194.3 K to 192.6 K (-0.91 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 30.80 | 2,797 | 86,134 | 194,338 | 197.1 K to 194.3 K (-1.42 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.95 | 7,209 | 86,148 | 197,135 | 189.9 K to 197.1 K (+3.80 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 30.80 | 3,739 | 115,143 | 189,926 | 193.7 K to 189.9 K (-1.93 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 30.80 | 5,079 | 156,408 | 193,665 | 198.7 K to 193.7 K (-2.56 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.95 | 13,091 | 156,437 | 198,744 | 185.7 K to 198.7 K (+7.05 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 14.62 | 1,376 | 20,117 | 185,653 | 184.3 K to 185.7 K (+0.75 %) |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | A | 16.02 | 42,099 | 674,426 | 42,099 | |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | A | 16.02 | 7,901 | 126,574 | 7,901 | |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 1,529 | 0 | 7,974 | 6.4 K to 8 K (+23.72 %) |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 10,000 | 0 | 184,277 | 174.3 K to 184.3 K (+5.74 %) |
Mar 02 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 17.11 | 1,846 | 31,585 | 174,277 | 176.1 K to 174.3 K (-1.05 %) |
Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 17.03 | 5,638 | 96,016 | 175,182 | 180.8 K to 175.2 K (-3.12 %) |
Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 180,820 | 165.8 K to 180.8 K (+9.05 %) |
Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 16.62 | 5,637 | 93,661 | 165,820 | 171.5 K to 165.8 K (-3.29 %) |
Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 171,457 | 156.5 K to 171.5 K (+9.59 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 5.73 | 2,404 | 13,775 | 0 | |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 5.73 | 2,500 | 14,325 | 2,404 | |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 5.73 | 96 | 550 | 0 | |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 5.73 | 12,500 | 71,625 | 96 | |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 8.75 | 1,574 | 13,773 | 156,457 | 158 K to 156.5 K (-1.00 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 5.73 | 2,404 | 13,775 | 158,031 | 155.6 K to 158 K (+1.54 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Payment of Exercise | F | 8.75 | 62 | 543 | 155,627 | 155.7 K to 155.6 K (-0.04 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 5.73 | 96 | 550 | 155,689 | 155.6 K to 155.7 K (+0.06 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 8.75 | 2,500 | 21,871 | 155,593 | 158.1 K to 155.6 K (-1.58 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 5.73 | 2,500 | 14,325 | 158,093 | 155.6 K to 158.1 K (+1.61 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 8.75 | 12,500 | 109,354 | 155,593 | 168.1 K to 155.6 K (-7.44 %) |
Oct 05 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 5.73 | 12,500 | 71,625 | 168,093 | 155.6 K to 168.1 K (+8.03 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | A | 15.03 | 19,781 | 297,308 | 19,781 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.13 | 5,000 | 55,625 | 350 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 5.73 | 2,500 | 14,325 | 4,904 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | A | 15.03 | 5,219 | 78,442 | 5,219 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.13 | 6,250 | 69,531 | 0 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 1,630 | 0 | 6,445 | 4.8 K to 6.4 K (+33.85 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 15.02 | 6,250 | 93,859 | 155,136 | 161.4 K to 155.1 K (-3.87 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.13 | 6,250 | 69,531 | 161,386 | 155.1 K to 161.4 K (+4.03 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 15.03 | 2,500 | 37,566 | 155,136 | 157.6 K to 155.1 K (-1.59 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 5.73 | 2,500 | 14,325 | 157,636 | 155.1 K to 157.6 K (+1.61 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 15.02 | 5,000 | 75,087 | 155,136 | 160.1 K to 155.1 K (-3.12 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.13 | 5,000 | 55,625 | 160,136 | 155.1 K to 160.1 K (+3.22 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Grant | A | 0.00 | 15,000 | 0 | 155,136 | 140.1 K to 155.1 K (+10.70 %) |
Feb 01 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.13 | 2,500 | 27,813 | 5,350 | |
Feb 01 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 16.16 | 2,500 | 40,409 | 151,639 | 154.1 K to 151.6 K (-1.62 %) |
Feb 01 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.13 | 2,500 | 27,813 | 154,139 | 151.6 K to 154.1 K (+1.65 %) |
Jan 18 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Option Exercise | M | 11.13 | 2,500 | 27,813 | 7,850 | |
Jan 18 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Sell | S | 15.00 | 2,500 | 37,500 | 151,639 | 154.1 K to 151.6 K (-1.62 %) |
Jan 18 2011 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP, Chief Medical ... | Buy | M | 11.13 | 2,500 | 27,813 | 154,139 | 151.6 K to 154.1 K (+1.65 %) |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Option Exercise | M | 14.28 | 5,436 | 77,632 | 0 | |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Option Exercise | M | 14.28 | 19,564 | 279,393 | 0 | |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Payment of Exercise | F | 17.98 | 4,317 | 77,620 | 149,983 | 154.3 K to 150 K (-2.80 %) |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Buy | M | 14.28 | 5,436 | 77,632 | 154,300 | 148.9 K to 154.3 K (+3.65 %) |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Payment of Exercise | F | 17.98 | 15,539 | 279,391 | 148,864 | 164.4 K to 148.9 K (-9.45 %) |
Feb 22 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Buy | M | 14.28 | 19,564 | 279,393 | 164,403 | 144.8 K to 164.4 K (+13.51 %) |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Option Exercise | A | 18.01 | 53,356 | 960,942 | 53,356 | |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Option Exercise | A | 18.01 | 6,644 | 119,658 | 6,644 | |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Grant | A | 0.00 | 1,360 | 0 | 4,815 | 3.5 K to 4.8 K (+39.36 %) |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | SVP Research & Dev ... | Grant | A | 17.83 | 412 | 7,346 | 144,839 | 144.4 K to 144.8 K (+0.29 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 42,186 | 380,518 | 92,186 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 50,000 | 451,000 | 50,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 2,814 | 25,382 | 2,814 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Feb 27 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 16,344 | 12,765 | 0 | |
Feb 27 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 16,344 | 12,765 | 143,265 | 126.9 K to 143.3 K (+12.88 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 11.80 | 585 | 6,903 | 126,921 | 126.3 K to 126.9 K (+0.46 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 4,344 | 14,253 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 1,096 | 3,185 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 163 | 535 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 5 | 2 | 0 | |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 5 | 2 | 126,221 | 126.2 K to 126.2 K (0.00 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 163 | 535 | 126,216 | 126.1 K to 126.2 K (+0.13 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 1,096 | 3,185 | 126,053 | 125 K to 126.1 K (+0.88 %) |
Mar 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 4,344 | 14,253 | 124,957 | 120.6 K to 125 K (+3.60 %) |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 24.87 | 60,980 | 1,516,573 | 60,980 | |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 24.87 | 4,020 | 99,977 | 4,020 | |
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 37.00 | 182 | 6,734 | 120,169 | 120 K to 120.2 K (+0.15 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 5,256 | 4,105 | 16,344 | |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 744 | 2,162 | 0 | |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 35.42 | 744 | 26,350 | 120,037 | 120.8 K to 120 K (-0.62 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 744 | 2,162 | 120,781 | 120 K to 120.8 K (+0.62 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 35.42 | 5,256 | 186,151 | 120,037 | 125.3 K to 120 K (-4.19 %) |
Jan 16 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 5,256 | 4,105 | 125,293 | 120 K to 125.3 K (+4.38 %) |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 11.95 | 6,700 | 80,065 | 13,091 | |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 37.20 | 6,700 | 249,253 | 120,037 | 126.7 K to 120 K (-5.29 %) |
Jan 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 11.95 | 6,700 | 80,065 | 126,737 | 120 K to 126.7 K (+5.58 %) |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 7,404 | |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 38.39 | 5,000 | 191,950 | 120,037 | 125 K to 120 K (-4.00 %) |
Dec 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 6,700 | 21,983 | 163 | |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 37.74 | 6,700 | 252,854 | 120,037 | 126.7 K to 120 K (-5.29 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 6,700 | 21,983 | 126,737 | 120 K to 126.7 K (+5.58 %) |
Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 12,404 | |
Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 41.68 | 5,000 | 208,392 | 120,037 | 125 K to 120 K (-4.00 %) |
Nov 19 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 6,700 | 19,470 | 744 | |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 44.02 | 6,700 | 294,915 | 120,037 | 126.7 K to 120 K (-5.29 %) |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 6,700 | 19,470 | 126,737 | 120 K to 126.7 K (+5.58 %) |
Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 17,404 | |
Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 47.70 | 5,000 | 238,475 | 120,037 | 125 K to 120 K (-4.00 %) |
Oct 17 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 125,037 | 120 K to 125 K (+4.17 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 11.13 | 3,400 | 37,825 | 10,350 | |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 3,300 | 31,763 | 7,900 | |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 49.77 | 3,400 | 169,210 | 119,530 | 122.9 K to 119.5 K (-2.77 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 11.13 | 3,400 | 37,825 | 122,930 | 119.5 K to 122.9 K (+2.84 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 49.77 | 3,300 | 164,233 | 119,530 | 122.8 K to 119.5 K (-2.69 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 3,300 | 31,763 | 122,830 | 119.5 K to 122.8 K (+2.76 %) |
Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 22,404 | |
Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 50.00 | 5,000 | 250,000 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
Sep 27 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 5.73 | 5,000 | 28,650 | 27,404 | |
Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.74 | 5,000 | 243,711 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
Sep 18 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 5.73 | 5,000 | 28,650 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 1,700 | 16,363 | 11,200 | |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 9.63 | 5,000 | 48,125 | 12,900 | |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.97 | 1,700 | 83,253 | 119,530 | 121.2 K to 119.5 K (-1.40 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 1,700 | 16,363 | 121,230 | 119.5 K to 121.2 K (+1.42 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 48.97 | 5,000 | 244,861 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 9.63 | 5,000 | 48,125 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |
Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.28 | 5,000 | 71,405 | 5,436 | |
Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.28 | 5,000 | 71,405 | 10,436 | |
Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 50.00 | 5,000 | 250,000 | 119,530 | 124.5 K to 119.5 K (-4.02 %) |
Aug 16 2007 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.28 | 5,000 | 71,405 | 124,530 | 119.5 K to 124.5 K (+4.18 %) |